A 12-Week,Double-Blind, Placebo-Controlled Trial of LY2428757 in Patients With Type 2 Diabetes Mellitus.
Phase of Trial: Phase II
Latest Information Update: 24 Aug 2016
At a glance
- Drugs LY 2428757 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 18 Feb 2010 Actual end date (Jan 2010) added as reported by ClinicalTrials.gov.
- 18 Feb 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.